Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials

By afschroeder • June 16, 2026

Waqas SA, Ibrahim M, Ahmed M, Waqas M, Aamir J, Fudim M, Musani MH, Fonarow GC, Greene SJ. Cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in patients without obesity: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord. 2026 Jun 13;25(1):158. doi: 10.1007/s40200-026-01969-6. PMID: 42299230; PMCID: PMC13264643.

Tags: Cardiology/Epi, cardiovascular outcomes, GLP1 receptor agonists, heart failure, MACE, meta-analysis, Non-obese, Publications

Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning

Dirakvand G, Pervin S, Villa B, Le C, Yohanna K, Grijalva V, Chattopadhyay A, Sinha SK, Reddy ST, Singh R. Follistatin Mitigates Atherosclerosis Through Activation[...]

Tenecteplase vs Alteplase and Time to Treatment for Acute Ischemic Stroke

Warach SJ, Weber JM, Alhanti B, Messé SR, Schwamm LH, Fonarow GC, Sheth KN, Smith EE, Mullen MT, Silva GS, Mac Grory B, Xian Y,[...]

Outcomes of Early Sodium-Glucose Cotransporter Two Inhibitor Use in Takotsubo Syndrome: Insights From a Multicenter Real-World Cohort Study

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]